Search All News
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
- June 9, 2014
A new study measures the risk of developing Parkinson's for people with Gaucher disease and Gaucher carriers.
- May 28, 2014
Columbia researchers have taken a significant step forward toward deciphering the genetics of schizophrenia, which could have important implications for early detection of the condition.
- May 21, 2014
A study of long-acting injectable antipsychotics for people with schizophrenia found that newer medication was no more effective than older, less expensive medication.
- May 15, 2014
Those with both migraine and vascular risk factors may want to pay even greater attention to lifestyle changes that can reduce stroke risk.
- May 15, 2014
NYP/CUMC promotes awareness of and offers expertise in a rare genetic disorder that causes tuberous growths in vital organs.
- May 13, 2014
Racial disparities in stroke are due primarily to higher rates and poorer treatment of hypertension, diabetes, and high cholesterol among black Americans.
- April 30, 2014
Researchers have identified two types of neurons that enable the spinal cord to control skilled forelimb movement. The findings could lead to new ways to treat movement disorders.
- April 20, 2014
Researchers from CUMC, Weill Cornell, and Brandeis have devised a new approach to the treatment of Alzheimer's involving the retromer protein complex.